CA1239347A - Formes posologiques liquides a liberation controlee - Google Patents

Formes posologiques liquides a liberation controlee

Info

Publication number
CA1239347A
CA1239347A CA000471918A CA471918A CA1239347A CA 1239347 A CA1239347 A CA 1239347A CA 000471918 A CA000471918 A CA 000471918A CA 471918 A CA471918 A CA 471918A CA 1239347 A CA1239347 A CA 1239347A
Authority
CA
Canada
Prior art keywords
coating
dosage forms
liquid
controlled release
liquid carrier
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA000471918A
Other languages
English (en)
Inventor
David L. Gardner
Ben F. Benton
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Battelle Development Corp
Original Assignee
Battelle Development Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Battelle Development Corp filed Critical Battelle Development Corp
Application granted granted Critical
Publication of CA1239347A publication Critical patent/CA1239347A/fr
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
CA000471918A 1984-01-13 1985-01-11 Formes posologiques liquides a liberation controlee Expired CA1239347A (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US57046984A 1984-01-13 1984-01-13
US570,469 1984-01-13

Publications (1)

Publication Number Publication Date
CA1239347A true CA1239347A (fr) 1988-07-19

Family

ID=24279767

Family Applications (1)

Application Number Title Priority Date Filing Date
CA000471918A Expired CA1239347A (fr) 1984-01-13 1985-01-11 Formes posologiques liquides a liberation controlee

Country Status (11)

Country Link
EP (1) EP0169236A1 (fr)
JP (1) JPS61500910A (fr)
AU (1) AU3835885A (fr)
CA (1) CA1239347A (fr)
ES (1) ES8605975A1 (fr)
GR (1) GR850069B (fr)
IL (1) IL74049A0 (fr)
IT (1) IT1184309B (fr)
NZ (1) NZ210785A (fr)
WO (1) WO1985003000A1 (fr)
ZA (1) ZA85239B (fr)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU207452B (en) * 1986-03-21 1993-04-28 Eurasiam Lab Method for producing therapeutical preparations containing active ingredient having biologicallu active protein structure
SE8605515D0 (sv) * 1986-12-22 1986-12-22 Astra Laekemedel Ab A liquid dosage form for oral administration of a pharmaceutically active substance
FI77573C (fi) * 1987-05-08 1989-04-10 Orion Yhtymae Oy Ny konsistens.
US5030454A (en) * 1987-10-26 1991-07-09 Alza Corporation Method for delivering drug in tiny pills in liquid carrier
US4853229A (en) * 1987-10-26 1989-08-01 Alza Corporation Method for adminstering tiny pills
US5296236A (en) * 1988-09-16 1994-03-22 Recordati S.A., Chemical And Pharmaceutical Company Controlled release therapeutic system for a liquid pharmaceutical formulations
IT1226940B (it) * 1988-09-16 1991-02-22 Recordati Chem Pharm Sistema terapeutico a rilascio controllato per formulazioni farmaceutiche liquide
US5202128A (en) * 1989-01-06 1993-04-13 F. H. Faulding & Co. Limited Sustained release pharmaceutical composition
DE69220317T2 (de) * 1991-10-01 1997-10-16 Takeda Chemical Industries Ltd Mikropartikeln-Zusammenfassung zur verlängerten Freigabe und Herstellung derselbe
IL104093A (en) * 1991-12-31 1999-06-20 Abbott Lab Prolamine is expected to mask the taste of drugs given orally
US5160742A (en) * 1991-12-31 1992-11-03 Abbott Laboratories System for delivering an active substance for sustained release
AU4198793A (en) † 1992-07-24 1994-01-27 Takeda Chemical Industries Ltd. Microparticle preparation and production thereof
US5744164A (en) * 1994-12-16 1998-04-28 Nestec S.A. Sustained release microparticulate caffeine formulation
DE60017881T2 (de) 1999-04-06 2006-04-13 Ethypharm Trinkbare pharmazeutische suspension von ibuprofen
FR2791888B1 (fr) * 1999-04-06 2004-10-08 Ethypharm Lab Prod Ethiques Suspension pharmaceutique buvable
FR2821745B1 (fr) * 2001-03-09 2004-07-02 Ethypharm Lab Prod Ethiques Granules et granules enrobes au gout masque
WO2004096175A2 (fr) * 2003-04-30 2004-11-11 Ranbaxy Laboratories Limited Compositions au gout masque et leurs procedes de preparation
KR20170052626A (ko) 2014-09-05 2017-05-12 심바이오믹스 세러퓨틱스 엘엘씨 세균질증 치료에 사용하기 위한 세크니다졸

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2805977A (en) * 1955-01-04 1957-09-10 Smith Kline French Lab Sustained release pharmaceutical preparation
US3265629A (en) * 1958-12-22 1966-08-09 Ncr Co Coating by phase separation
US3432593A (en) * 1963-09-18 1969-03-11 Key Pharm Inc Delayed and sustained release type pharmaceutical preparation

Also Published As

Publication number Publication date
JPS61500910A (ja) 1986-05-08
WO1985003000A1 (fr) 1985-07-18
IL74049A0 (en) 1985-04-30
IT1184309B (it) 1987-10-28
EP0169236A1 (fr) 1986-01-29
ES8605975A1 (es) 1986-04-01
NZ210785A (en) 1987-11-27
GR850069B (fr) 1985-05-03
ES539500A0 (es) 1986-04-01
ZA85239B (en) 1985-08-28
IT8519086A0 (it) 1985-01-11
AU3835885A (en) 1985-07-30

Similar Documents

Publication Publication Date Title
CA1239347A (fr) Formes posologiques liquides a liberation controlee
US4876094A (en) Controlled release liquid dosage formulation
EP0619733B1 (fr) Systeme d'apport d'une substance active a liberation prolongee
EP0327086B1 (fr) Granule multicouche
US4415547A (en) Sustained-release pharmaceutical tablet and process for preparation thereof
DK175812B1 (da) Flydende præparat med forbedrede egenskaber til peroral administrering
US4574080A (en) Combination formulation
EP0235718B1 (fr) Granule retenu dans l'estomac
US4806361A (en) Medicaments in sustained release unit dose form
US2410417A (en) Vitamin and mineral dietary supplement and method of making
US4828840A (en) Sustained-release formulation and production thereof
TWI285118B (en) Timed dual release dosage forms comprising a short acting hypnotic or a salt thereof
US5043167A (en) Galenic formulations with programmed release
JPH0615468B2 (ja) 放出調整複合単位組成物の製法
FI96095B (fi) Menetelmä jatkuvavapautteisen lääkevalmisteen valmistamiseksi
AU2003285189B2 (en) Oral testosterone delivery system with improved sustained release
IL131508A (en) Micronexulatory formulations and controlled dispersion of isoflavins from rich masses of sesame and other plants
GB2204241A (en) Fat coated pharmaceutical compositions
AU2016324349A1 (en) Ubiquinone and ubiquinol compositions, and methods relating thereto
JPS63188621A (ja) 矯味経口製剤
CA1261268A (fr) Preparation de theophylline a liberation continue
AU2021203468A1 (en) Pharmaceutical compositions having high drug loadings of medium chain triglycerides and methods related thereto
US4600577A (en) Pharmaceutical preparations of pinacidal
WO1982001468A1 (fr) Nouvelle forme galenique d'administration du metoclopramide, son procede de preparation et medicament comprenant cette nouvelle forme
KR20020031338A (ko) 모르핀술페이트 마이크로그래뉼, 이의 제조방법 및 이를함유하는 조성물

Legal Events

Date Code Title Description
MKEX Expiry